Successful treatment with ganciclovir for cytomegalovirus duodenitis following allogenic bone marrow transplantation
The Korean Journal of Internal Medicine
;
: 91-94, 1999.
Article
in English
| WPRIM
| ID: wpr-125506
ABSTRACT
Cytomegalovirus(CMV) disease is a major cause of morbidity and mortality in immunocompromised patients. CMV enteritis should be considered when nausea and vomiting continue 3 to 4 weeks after bone marrow transplantation(BMT). The treatment of CMV enteritis is not well established. We report a CMV duodenitis patient following allogenic bone marrow transplantation. The patient had prolonged nausea and vomiting for 5 weeks after bone marrow transplantation and CMV duodenitis was diagnosed by the gastroduodenoscopic mucosal biopsy which showed cytomegalic cells. Ganciclovir treatment for 3 weeks resulted in the resolution of symptoms and promoted healing of the lesion. The patient was free of CMV infection until 288 days after allogenic BMT without maintenance ganciclovir treatment.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Antiviral Agents
/
Transplantation, Homologous
/
Ganciclovir
/
Bone Marrow Transplantation
/
Cytomegalovirus Infections
/
Duodenitis
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
The Korean Journal of Internal Medicine
Year:
1999
Type:
Article
Similar
MEDLINE
...
LILACS
LIS